Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC)

Historical Holders from Q2 2021 to Q3 2025

Symbol
IPSC on Nasdaq
CUSIP
15673T100
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
86.3M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
20.3M
Holdings value
$10.1M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
53
Number of buys
13
Number of sells
-40
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Venrock Healthcare Capital Partners III, L.P. 4.7% $2.1M 3.96M Venrock Healthcare Capital Partners III, L.P. Dec 31, 2024
Bain Capital Life Sciences Opportunities III, LP 4.1% $1.76M 3.54M Bain Capital Life Sciences Opportunities III, LP Sep 30, 2025
Casdin Capital, LLC 3.7% $1.7M 3.21M Casdin Capital, LLC Mar 31, 2025

Institutional Holders of Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 20.3M $10.1M -$1.2M $0.50 53
2025 Q2 22.6M $12.6M -$3.58M $0.56 64
2025 Q1 29.6M $14.1M -$4.28M $0.48 69
2024 Q4 36.4M $36.8M -$7.77M $1.01 70
2024 Q3 39.6M $67.8M -$1.21M $1.71 66
2024 Q2 40.1M $102M +$41M $2.55 59
2024 Q1 23.1M $96.6M +$22.9M $4.18 65
2023 Q4 17.7M $58.7M -$544K $3.32 60
2023 Q3 18.1M $36.1M -$2.77M $2.00 53
2023 Q2 19.3M $61M -$2.35M $3.16 62
2023 Q1 20M $69.5M -$4.62M $3.47 63
2022 Q4 20.9M $107M -$3.63M $5.13 66
2022 Q3 21.1M $209M -$4.94M $9.89 54
2022 Q2 21.8M $183M -$3.24M $8.40 51
2022 Q1 22.2M $279M +$11.5M $12.59 51
2021 Q4 21.1M $335M +$24.3M $15.86 50
2021 Q3 19.8M $496M +$62.1M $25.16 47
2021 Q2 16.9M $491M +$491M $29.34 35